EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Journey Medical's Enterprise Value is $56.86 Mil.
Journey Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $0.24 Mil. Therefore, Journey Medical's EV-to-FCF for today is 236.90.
The historical rank and industry rank for Journey Medical's EV-to-FCF or its related term are showing as below:
DERM'
s EV-to-FCF Range Over the Past 10 Years
Min: -21.9 Med: -1.2 Max: 355.27
Current: 236.9
During the past 5 years, the highest EV-to-FCF of Journey Medical was 355.27. The lowest was -21.90. And the median was -1.20.
DERM's EV-to-FCF is ranked worse than 93.7% of 508
companies
in the Drug Manufacturers industry
Industry Median: 21.86
vs DERM: 236.90
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-24), Journey Medical's stock price is $3.40.
Journey Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.350. Therefore, Journey Medical's PE Ratio for today is At Loss.
Journey Medical EV-to-FCF Historical Data
The historical data trend for Journey Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Journey Medical's EV-to-FCF
For the Drug Manufacturers - Specialty & Generic subindustry, Journey Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Journey Medical EV-to-FCF Distribution
For the Drug Manufacturers industry and Healthcare sector, Journey Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Journey Medical's EV-to-FCF falls into.
Journey Medical EV-to-FCF Calculation
Journey Medical's EV-to-FCF for today is calculated as:
Journey Medical's current Enterprise Value is $56.86 Mil.
Journey Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Journey Medical (NAS:DERM) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Journey Medical's PE Ratio for today is calculated as:
Journey Medical's share price for today is $3.40.
Journey Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.350.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Journey Medical EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Journey Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Journey Medical (Journey Medical) Business Description
Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm, etc.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DERM has been successfully added to your 